Pharmafile Logo

Goffin Consultancy Ltd

We are a consultancy, set up in early 1999, specialising in health economic analysis and systematic reviews of clinical data. We may be relatively small but we have an unusual depth of experience of the pharmaceutical industry – and if we don’t know, we almost certainly know someone who does! We also have a wide medical expertise in all aspects of medical and regulatory affairs and are able to assist smaller companies directly or on behalf of Private Equity / Venture Capitol companies. Depending on the project, we can bring in experts in a variety of fields including: medical affairs; market research, surveys; strategic planning; sales; market commercialization.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Riding House, Bossingham Road, Stelling Minnis, Canterbury, Kent, CT4 6AZ, United Kingdom
+44 (0)122 7709220

 Latest Content from PMHub 

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach

Commercial innovation in biotech organisations

Blue Latitude Health speaks to Salma Jutt Vice President of US Marketing and Head of Commercial Innovation at a biotech specialising in treating weight loss and obesity.

Conducting market research for scientific publication guide

Conducting and using market research for publication can be valuable for shaping opinions in healthcare. The findings can be used to influence existing perceptions, change current practices and behaviour in...

Therapy Watch appoints new Associate Director

Research Partnership has appointed Mark Hollis to join the Therapy Watch team as Associate Director. Mark has 8 years’ experience in syndicated healthcare, and previously worked in the Market Prognosis team at IQVIA...

Sabera Hyderally appointed Head of MedTech North America

Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.

Full speed ahead: Unlock the full potential of your brand tracking

Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Lucid Group are on the Lookout for World-Shaking Talent

Lucid Group kick-started the week with its second exchange day in 2018, held in their Macclesfield office. With continued growth from new and existing clients, the need to find and...

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

HSJ Awards open for entry with promise to champion NHS on its 70th anniversary

New insights into making behavioural change work

The focus of pharmacological interventions has experienced a shift over recent years, with a greater emphasis placed on addressing lifestyle conditions than on fighting infectious diseases. Lifestyle conditions, or noncommunicable...